Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial.
about
Stroke Event Rates and the Optimal Antithrombotic Choice of Patients With Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsThromboembolic risk and effect of oral anticoagulation according to atrial fibrillation patterns: A systematic review and meta-analysisHigher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial.Effects of body mass index on risks for ischemic stroke, thromboembolism, and mortality in Chinese atrial fibrillation patients: a single-center experience.ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives.Type of Atrial Fibrillation and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≤1 and without anticoagulant therapy.Association of atrial fibrillation with gene polymorphisms of connexin 40 and angiotensin II receptor type 1 in Chongming adults of Shanghai.Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation.Temporal pattern/episode duration-based classification of atrial fibrillation as paroxysmal vs. persistent: is it time to develop a more integrated prognostic score to optimize management?3D-computed tomography to compare the dimensions of the left atrial appendage in patients with normal sinus rhythm and those with paroxysmal atrial fibrillation.Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES.
P2860
Q26771564-EF6B9398-DC3A-4180-BE6D-31B0998D85D0Q29994528-9996F628-59D6-4478-BF54-7BD4C59A9A12Q35036404-954D7859-2B62-4471-8521-6870F1CB266BQ35305757-46D116EC-093F-4AB1-BEF5-EF155502F21FQ38650658-09A62AAB-9505-413E-8923-F3E115565B34Q40049684-1157C2E5-BC34-4587-B146-6B25DC499387Q40672562-D0B8F7D6-C8DD-4F24-87F8-45CDA6B64A9DQ43183347-1BDD948A-5A99-419F-A469-A2B9E6F80802Q47106384-08838559-3E83-410B-B679-179919994FA5Q47827668-B9A240D2-74C5-4AB5-BA2D-B43296A46D03Q48250577-E031C627-57DA-4A4E-BA51-56ACA7E21DFBQ48565298-C27596A0-713C-4DB8-9543-E42DD4D1E6B1
P2860
Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Thromboembolic event rate in p ...... data from the GISSI-AF trial.
@ast
Thromboembolic event rate in p ...... data from the GISSI-AF trial.
@en
Thromboembolic event rate in p ...... data from the GISSI-AF trial.
@nl
type
label
Thromboembolic event rate in p ...... data from the GISSI-AF trial.
@ast
Thromboembolic event rate in p ...... data from the GISSI-AF trial.
@en
Thromboembolic event rate in p ...... data from the GISSI-AF trial.
@nl
prefLabel
Thromboembolic event rate in p ...... data from the GISSI-AF trial.
@ast
Thromboembolic event rate in p ...... data from the GISSI-AF trial.
@en
Thromboembolic event rate in p ...... data from the GISSI-AF trial.
@nl
P2093
P2860
P356
P1476
Thromboembolic event rate in p ...... data from the GISSI-AF trial.
@en
P2093
Chiara Favero
Franco Cosmi
GISSI-AF investigators
Gianna Fabbri
Glauco Cappellini
Lidia Staszewsky
Luigi Andrea Moroni
Marcello Disertori
Maria Grazia Franzosi
Roberto Latini
P2860
P2888
P356
10.1186/1471-2261-13-28
P577
2013-04-15T00:00:00Z
P5875
P6179
1011655469